Since scientists in South Africa announced the discovery last week of a COVID-19 variant now known as omicron, researchers around the world have been trying to get a handle on the type of threat it poses. South African Health Minister Joe Phaahla said on December 3 that only a small number of vaccinated people have been infected by the omicron …
No evidence yet to support a change in vaccines as they are ‘highly effective’, the World Health Organization says. The World Health Organization’s chief scientist has urged people not to panic over the emergence of the Omicron coronavirus variant and said it was too early to say if vaccines would need to be reworked. Swaminathan said Omicron appeared to be …
At least four drug makers are rushing to confirm the efficacy of their COVID-19 vaccines against the new fast-spreading variant of the virus detected in the UK. Key points: The new strain of the novel coronavirus may up to 70 per cent more infectious The new strain of the novel coronavirus may up to 70 per cent more infectious But …
LOADING ERROR LOADING All eyes were on Coventry Hospital early on Tuesday morning as 90-year-old Margaret Keenan became the first patient in the world to be injected with Pfizer/BioNTech’s Covid-19 vaccine. Here’s a look at the people around the world who have got us to this point: The nurse who administered the first dose On Tuesday morning May Parsons, who …
Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to seek emergency use of limited shot supplies as the catastrophic outbreak worsens across the globe. But next year if several companies’ vaccine candidates also work, “we might be …
BioNTech is planning to price its experimental COVID-19 vaccine below "typical market rates" and would differentiate pricing between countries or regions, according to a report by Reuters. Speaking at a Financial Times online event, the German biotech firm's strategy head Ryan Richardson said the price tag of the vaccine would reflect the financial risks that its private-sector investors have incurred. …
Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards their experimental immunisations will be held against in the global race to contain the coronavirus pandemic. Nine of the companies leading the international race to make coronavirus vaccines pledged on Tuesday that they would stick to scientific rigor and not bow to political pressure to …